Microsomal prostaglandin E2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarction.
BACKGROUND
Pharmacological inhibition of cyclooxygenase-2 increases the risk of myocardial infarction (MI) and stroke. Microsomal prostaglandin (PG) E(2) synthase-1 (mPGES-1), encoded by the Ptges gene, functions downstream from cyclooxygenase-2 in the inducible PGE(2) biosynthetic pathway. We caused acute MI in Ptges(+/+) and Ptges(-/-) mice to define the role of mPGES-1 in cardiac ischemic injury.


RESULTS
Twenty-eight days after MI, Ptges(-/-) mice develop more left ventricular (LV) dilation, have worse LV systolic and diastolic function, and have higher LV end-diastolic pressure than Ptges(+/+) mice but have similar pulmonary wet-to-dry weight ratios, cardiac mass, infarct size, and mortality. The length-to-width ratio of individual cardiomyocytes is significantly greater in Ptges(-/-) than Ptges(+/+) mice after MI, a finding consistent with eccentric cardiomyocyte hypertrophy in Ptges(-/-) mice. Expression of atrial natriuretic peptide, brain natriuretic peptide, and alpha- and beta-myosin heavy chain, markers of ventricular hypertrophy, is higher in the LV of Ptges(-/-) than Ptges(+/+) mice after MI. Ptges(+/+) mice express cyclooxygenase-2 and mPGES-1 protein in inflammatory cells adjacent to the infarct after MI but do not express these proteins in cardiomyocytes. Ptges(-/-) mice express cyclooxygenase-2 in inflammatory cells adjacent to the infarct and do not express mPGES-1 in any cells in the heart. Levels of PGE(2) but not PGD(2), thromboxane A(2), PGI(2), or PGF(2alpha) are higher in the infarct and LV remote from the infarct after MI in Ptges(+/+) than Ptges(-/-) mice.


CONCLUSIONS
In Ptges(+/+) mice, mPGES-1 in inflammatory cells catalyzes PGE(2) biosynthesis in the LV after MI. Deletion of mPGES-1 leads to eccentric cardiac myocyte hypertrophy, LV dilation, and impaired LV contractile function after acute MI.
Degousee
Norbert
N
Division of Vascular Surgery, University of Toronto, Toronto, Ontario, Canada M5G-2C4.
Fazel
Shafie
S
Angoulvant
Denis
D
Stefanski
Eva
E
Pawelzik
Sven-Christian
SC
Korotkova
Marina
M
Arab
Sara
S
Liu
Peter
P
Lindsay
Thomas F
TF
Zhuo
Sun
S
Butany
Jagdish
J
Li
Ren-Ke
RK
Audoly
Laurent
L
Schmidt
Ronald
R
Angioni
Carlo
C
Geisslinger
Gerd
G
Jakobsson
Per-Johan
PJ
Rubin
Barry B
BB
D000818:Animals; D017353:Gene Deletion; D019746:Intramolecular Oxidoreductases / Q000172:deficiency* / Q000235:genetics* / Q000502:physiology; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D018345:Mice, Knockout; D008861:Microsomes / Q000201:enzymology*; D009203:Myocardial Infarction / Q000201:enzymology* / Q000235:genetics / Q000503:physiopathology*; D000071876:Prostaglandin-E Synthases; D020257:Ventricular Remodeling / Q000235:genetics* / Q000502:physiology
D019746:Intramolecular Oxidoreductases; D000071876:Prostaglandin-E Synthases; C000605865:Ptges protein, mouse